Skip to content
Home/Companies/Biotech/Artax Biopharma
Artax Biopharma

Artax Biopharma

Biotech·United States·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns Artax Biopharma?

Artax Biopharma is currently owned by Columbus Venture Partners through Columbus Innvierte Life Science Fund I (2016 vintage), since 2020.

Hand-verified · updated 2026-08-09

Columbus Venture Partners
Investor
Columbus Venture Partners
Columbus Innvierte Life Science Fund I · 2016 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Websiteartaxbiopharma.com

More from Columbus Innvierte Life Science Fund I

Other portfolio companies in the same fund.

Aura Biosciences
Exited 2021
BiotechUnited States· 2018
TAAV
Exited 2020
BiotechSpain· 2018
to
Viralgen
Exited 2020
BiotechSpain· 2018
to
Algenex
Exited 2022
BiotechSpain· 2017
to
Curapath
Curapath
Exited 2021
PharmaSpain· 2017
to
Vivet Therapeutics
Vivet Therapeutics
Active
BiotechFrance· 2017

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Artax Biopharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Artax Biopharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue